← Back to headlines
Roivant Pipeline Gains Momentum After Mosliciguat Data
Roivant Sciences presented at the Cantor conference, highlighting momentum in its pipeline following positive data from mosliciguat trials.
9 Sept, 20:38 — 9 Sept, 20:38
Sources
Showing 1 of 1 sources
